CD8A and metastatic melanoma: In a study by Fairfax et al. that examined the characteristics of peripheral CD8+ T cells in relation to ICI in patients with metastatic melanoma, they explored the properties of the peripheral TCR repertoire for association with clinical outcomes [13].